Shareholders' Equity - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common shares authorized (in shares)	100,000,000	100,000,000
Authorized preferred stock (in shares)	50,000,000	50,000,000
Number of shares available for grant (in shares)	1,600,000
Dividends declared		$ 2,700	$ 10,800
Total Shareholders’ Equity	$ 1,201,749	1,111,980	1,104,018	$ 1,428,387
Total authorizations which remain available for use	55,900
Deferred tax expense (benefit) included in OCI	9,100	$ 25,100	$ (85,200)
Retained Earnings, Unappropriated
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Shareholders’ Equity	$ 462,400